The weekly litigation news digest is live. Subscribe now

IP Verse

Universal Anti-Tag Chimeric Antigen Receptor-Expressing T Cells And Methods Of Treating Cancer - EP2651442

The patent EP2651442 was granted to University OF Maryland on Apr 22, 2020. The application was filed on Dec 14, 2011 under application number EP11849221A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2651442

UNIVERSITY OF MARYLAND
Application Number
EP11849221A
Filing Date
Dec 14, 2011
Status
Granted And Under Opposition
Mar 20, 2020
Publication Date
Apr 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
STRAWMANJan 21, 2021POTTER CLARKSONADMISSIBLE
AVENCELL EUROPEJan 20, 2021KAILUWEIT & UHLEMANN PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS4946778
OPPOSITIONUS2003175288
OPPOSITIONUS2005113561
OPPOSITIONUS2007172504
OPPOSITIONUS2008003225
OPPOSITIONUS2009011984
OPPOSITIONUS2010278830
OPPOSITIONWO0190198
OPPOSITIONWO2012082841

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents